[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Yoo J.J., Kim W., Kim M.Y., Jun D.W., Kim S.G., Yeon J.E., Lee J.W., Cho Y.K., Park S.H., Sohn J.H
The plaintiffs of these lawsuits want to hold manufacturers like Novo Nordisk accountable for not highlighting the seriousness of the side effects that these medications have
Exendin-4, a Glucagon-like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
doi:10.1007/s40618-014-0137-y Tanday N, Flatt PR, Irwin N
Clinically supported ingredients for weight loss & fat metabolism
DDI Automation Brings NetSecOps Together Finally, DDI solutions that automate infrastructure management are important enablers of NetSecOps collaboration